| scholarly article | Q13442814 |
| P2093 | author name string | Wadsworth SC | |
| Vincent KA | |||
| Piraino ST | |||
| P2860 | cites work | Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein | Q24309481 |
| Site-specific integration by adeno-associated virus | Q24558738 | ||
| A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions | Q24597783 | ||
| Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels | Q24646235 | ||
| Regulation of adeno-associated virus gene expression in 293 cells: control of mRNA abundance and translation | Q24646629 | ||
| Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors | Q24682739 | ||
| Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis | Q24684374 | ||
| Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase | Q26778389 | ||
| Selective extraction of polyoma DNA from infected mouse cell cultures | Q29547500 | ||
| Characteristics of a human cell line transformed by DNA from human adenovirus type 5 | Q29547863 | ||
| Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells | Q33914608 | ||
| Latent infection of KB cells with adeno-associated virus type 2 | Q33927814 | ||
| Amber, ochre and opal suppressor tRNA genes derived from a human serine tRNA gene. | Q33930874 | ||
| Purification of an adenovirus-coded DNA polymerase that is required for initiation of DNA replication | Q53563525 | ||
| Replication of a human parvovirus nonsense mutant in mammalian cells containing an inducible amber suppressor | Q64379115 | ||
| Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung | Q64382719 | ||
| Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein | Q34057580 | ||
| Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells | Q35228018 | ||
| Adeno-associated virus vectors | Q35305418 | ||
| Adeno-associated virus vectors preferentially transduce cells in S phase. | Q35754006 | ||
| Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. | Q35833899 | ||
| Targeted integration of adeno-associated virus (AAV) into human chromosome 19 | Q35936149 | ||
| Selection and preliminary characterization of temperature-sensitive mutants of type 5 adenovirus | Q36588367 | ||
| Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins | Q36624044 | ||
| Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein. | Q36624752 | ||
| Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. | Q36634983 | ||
| Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector | Q36663364 | ||
| Adeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells | Q36688082 | ||
| Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein | Q36693546 | ||
| Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor | Q36829959 | ||
| Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression | Q36830429 | ||
| Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein | Q36831270 | ||
| Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes | Q36838187 | ||
| Adeno-associated virus general transduction vectors: analysis of proviral structures | Q36868692 | ||
| Identification of the trans-acting Rep proteins of adeno-associated virus by antibodies to a synthetic oligopeptide | Q36869164 | ||
| Positive and negative autoregulation of the adeno-associated virus type 2 genome | Q36883901 | ||
| Negative and positive regulation in trans of gene expression from adeno-associated virus vectors in mammalian cells by a viral rep gene product | Q36918659 | ||
| Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters | Q39871566 | ||
| High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant | Q39872328 | ||
| Adeno-associated virus type 2 rep gene-mediated inhibition of basal gene expression of human immunodeficiency virus type 1 involves its negative regulatory functions. | Q40039173 | ||
| Cell lines inducibly expressing the adeno-associated virus (AAV) rep gene: requirements for productive replication of rep-negative AAV mutants | Q40042369 | ||
| The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification | Q40109360 | ||
| Adeno-associated virus vectors for gene therapy | Q40429008 | ||
| The cryptic life style of adeno-associated virus | Q40524042 | ||
| Prospects for the use of adeno-associated virus as a vector for human gene therapy | Q40643988 | ||
| Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types | Q40660263 | ||
| High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors | Q41263327 | ||
| Cell lines for the production of recombinant adeno-associated virus | Q41286219 | ||
| Generation of recombinant adeno-associated virus (rAAV) from an adenoviral vector and functional reconstitution of the NADPH-oxidase | Q41304538 | ||
| Regulated high-level human beta-globin gene expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer | Q41329085 | ||
| An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. | Q41396968 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Gene expression in adeno-associated virus vectors: the effects of chimeric mRNA structure, helper virus, and adenovirus VA1 RNA. | Q42500842 | ||
| Adeno-associated virus type 2-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) replication: involvement of p78rep/p68rep and the HIV-1 long terminal repeat | Q43712032 | ||
| Epidemiology of adenovirus-associated virus infection in a nursery population | Q44631695 | ||
| A BASIC computer program for analyzing endpoint assays | Q44845101 | ||
| Efficient synthesis of adeno-associated virus structural proteins requires both adenovirus DNA binding protein and VA I RNA. | Q45846371 | ||
| Increased titer of recombinant AAV vectors by gene transfer with adenovirus coupled to DNA-polylysine complexes | Q45867335 | ||
| Establishment and characterization of KB cell lines latently infected with adeno-associated virus type 1 | Q45887287 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1897-1905 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products | |
| P478 | volume | 71 |
| Q40916579 | A helper virus-free packaging system for recombinant adeno-associated virus vectors |
| Q40894016 | A method for the preparation of highly purified adeno-associated virus using affinity column chromatography, protease digestion and solvent extraction |
| Q40994121 | Adeno-associated virus expression systems for gene transfer |
| Q24563214 | Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus |
| Q28208569 | Adenovirus encoding HIV-1 Vpr activates caspase 9 and induces apoptotic cell death in both p53 positive and negative human tumor cell lines |
| Q39581575 | An adenovirus type 5 mutant with the preterminal protein gene deleted efficiently provides helper functions for the production of recombinant adeno-associated virus |
| Q33784934 | Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination |
| Q40619808 | Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions |
| Q39882175 | Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins. |
| Q97527299 | Creation of a High-Yield AAV Vector Production Platform in Suspension Cells Using a Design-of-Experiment Approach |
| Q36288924 | Current issues in adeno-associated viral vector production |
| Q40949297 | Efficient production of adeno-associated virus vectors using split-type helper plasmids |
| Q24527221 | Efficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal size |
| Q39682511 | Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes |
| Q33607774 | Gene transfer approaches to the lysosomal storage disorders |
| Q42448457 | Herpes simplex virus type 1/adeno-associated virus hybrid vectors |
| Q34447817 | Hot topics in adeno-associated virus as a gene transfer vector |
| Q35891981 | Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production |
| Q39941005 | Improved splicing of adeno-associated viral (AAV) capsid protein-supplying pre-mRNAs leads to increased recombinant AAV vector production |
| Q35159598 | Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degeneration. |
| Q89932125 | MicroRNA-based recombinant AAV vector assembly improves efficiency of suicide gene transfer in a murine model of lymphoma |
| Q41634721 | New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors |
| Q44953303 | Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization. |
| Q44586325 | Optimization of packaging of adeno-associated virus gene therapy vectors using plasmid transfections |
| Q40793707 | Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system |
| Q33783728 | Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors |
| Q24523073 | Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus |
| Q34070162 | Production of recombinant adeno-associated virus |
| Q40937480 | Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus |
| Q28478598 | Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFα |
| Q40746271 | Recombinant adeno-associated viral vector production using stable packaging and producer cell lines |
| Q39882313 | Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap |
| Q40705869 | Replication competent helper functions for recombinant AAV vector generation |
| Q39880225 | Role for highly regulated rep gene expression in adeno-associated virus vector production |
| Q43567043 | Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2. |
| Q37134005 | Toward exascale production of recombinant adeno-associated virus for gene transfer applications |
| Q37479802 | Transient transfection methods for clinical adeno-associated viral vector production |
| Q43546899 | Viral delivery of recombinant short hairpin RNAs |
Search more.